Comments
Loading...
Zai Lab (NASDAQ:ZLAB) Stock Quotes, Forecast and News Summary
Zai Lab Stock (NASDAQ: ZLAB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zai Lab (ZLAB) stock?
You can purchase shares of Zai Lab (NASDAQ:ZLAB) through any online brokerage.
Who are Zai Lab (ZLAB) competitors?
Other companies in Zai Lab’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Zai Lab (ZLAB) stock?
Zai Lab has a consensus price target of $64.72.
What is the current price for Zai Lab (ZLAB)?
The stock price for Zai Lab (NASDAQ: ZLAB) is $32.86 last updated February 24, 2025 at 9:56 AM EST.
Does Zai Lab (ZLAB) pay a dividend?
There are no upcoming dividends for Zai Lab.
When is Zai Lab (NASDAQ:ZLAB) reporting earnings?
Zai Lab’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Zai Lab (ZLAB) going to split?
There is no upcoming split for Zai Lab.
What sector and industry does Zai Lab (ZLAB) operate in?
Zai Lab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.